Public healthcare funding modifies the effect of out-of-pocket spending on maternal, infant, and child mortality by Noel, Jonathan K
Johnson & Wales University
ScholarsArchive@JWU
Health & Wellness Department Faculty
Publications and Research College of Health & Wellness
2017
Public healthcare funding modifies the effect of
out-of-pocket spending on maternal, infant, and
child mortality
Jonathan K. Noel
Johnson & Wales University - Providence, Jonathan.Noel@jwu.edu
Follow this and additional works at: https://scholarsarchive.jwu.edu/health_fac
Part of the Medicine and Health Sciences Commons
This Article is brought to you for free and open access by the College of Health & Wellness at ScholarsArchive@JWU. It has been accepted for inclusion
in Health & Wellness Department Faculty Publications and Research by an authorized administrator of ScholarsArchive@JWU. For more information,
please contact jcastel@jwu.edu.
Repository Citation
Noel, Jonathan K., "Public healthcare funding modifies the effect of out-of-pocket spending on maternal, infant, and child mortality"
(2017). Health & Wellness Department Faculty Publications and Research. 47.
https://scholarsarchive.jwu.edu/health_fac/47
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=uhcw20
Health Care for Women International
ISSN: 0739-9332 (Print) 1096-4665 (Online) Journal homepage: https://www.tandfonline.com/loi/uhcw20
Public health care funding modifies the effect of
out-of-pocket spending on maternal, infant, and
child mortality
Jonathan K. Noel
To cite this article: Jonathan K. Noel (2017) Public health care funding modifies the effect of out-
of-pocket spending on maternal, infant, and child mortality, Health Care for Women International,
38:3, 253-266, DOI: 10.1080/07399332.2016.1254217
To link to this article:  https://doi.org/10.1080/07399332.2016.1254217
View supplementary material 
Accepted author version posted online: 31
Oct 2016.
Published online: 29 Dec 2016.
Submit your article to this journal 
Article views: 133
View Crossmark data
Public health care funding modifies the effect of out-of-
pocket spending on maternal, infant, and child mortality
Jonathan K. Noel
Department of Community Medicine and Health Care, University of Connecticut School of Medicine,
Farmington, Connecticut, USA
ARTICLE HISTORY
Received 27 January 2015
Accepted 25 October 2016
ABSTRACT
Increased out-of-pocket (OOP) health care spending has been
associated with increased maternal, infant, and child mortality,
but the effect of public health care spending on mortality has
not been studied. I identified a statistically significant interaction
between public health care expenditure and OOP health care
spending for maternal, infant, and child mortality. Generally,
increases in public expenditure coincide with decreased rates of
mortality, regardless of OOP spending levels. Specifically, higher
levels of public expenditure with moderate levels of OOP
spending may result in the lowest mortality rates. Increased
public health care spending may improve health outcomes
better than efforts to reduce OOP expenditure alone.
Introduction
Maternal, infant, and child mortality remain significant public health issues, partic-
ularly in the developing world. Among 289,000 maternal deaths worldwide in
2013, 286,000 occurred in developing countries (World Health Organization
[WHO], 2014), and up to two-thirds of infant newborn deaths and more than half
of all deaths among children under 5 are preventable with effective health meas-
ures (World Health Organization, 2012; World Health Organization, 2014). Other
researchers have noted that systematic structural changes to health care systems,
such as increased construction of government run health care facilities, have
decreased mortality rates, but few studies have focused on the effect of out-of-
pocket (OOP) spending (Liljestrand & Sambath, 2012). The WHO has previously
stated the reducing required OOP spending is a key step toward universal health
care access and, ultimately, better health outcomes (Evans, Elovainio, & Hum-
phreys, 2010).
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Consisting of official payments made directly to health care providers and insti-
tutions (i.e., direct payments), charges for services that are intended to be free (i.e.,
informal payments), and transportation, housing and food-related costs (i.e., indi-
rect costs), OOP spending is considered the primary financial barrier to accessing
health care, particularly in low- and middle-income countries such as Tanzania
(2015 GDP per capita D US$865) and Serbia (2015 GDP per capita D US$5,144)
(World Health Organization, 2010; Arsenijevic, Pavlova, & Groot, 2014; Saksena
et al., 2010). Leading categories of OOP spending include food, transportation,
and pharmaceuticals, with transportation costs contributing up to 50% of total
OOP expenses in developing countries, such as Tanzania (Kruk, Mbaruku, Rock-
ers, & Galea, 2008; Saksena et al., 2010). In Canada, food and travel costs comprise
up to three-quarters of OOP spending associated with childhood cancer treatment
(Tsimicalis et al., 2013). OOP spending at the point of service is also relatively
common. In Kenya, Burkina Faso, and Tanzania, 98%, 92%, and 91% of women
paid OOP costs for care during childbirth, respectively, and in Nigeria, 95% of
individuals financed malaria treatments through OOP spending (Onwujekwe et
al., 2010; Perkins et al., 2009). Moreover, the presence of a government-run health
care system may not obviate the need for OOP spending. In India, 80% of 9,643
households financed maternal health services OOP due to inadequate public health
care facilities (Leone, James, & Padmadas, 2013).
The extent of OOP spending varies by country (Figure 1) and condition. In the
United States, mean OOP spending on asthma medication was estimated to be (in
2010 US$) $154 per year for children aged 5–18 years old between 1997 and 2007,
while OOP spending for children with influenza can exceed (in 2009 US$) $1,400
per occurrence for children requiring hospitalization (Karaca-Mandic, Jena, Joyce,
& Goldman, 2012; Ortega-Sanchez et al., 2012). In the United Kingdom, families
of children diagnosed with Autism Spectrum Disorder (ASD) spent (in 2007 U.
K.£) approximately £500 per month in direct costs and lost wages in 2006 and
2007, and mean annual OOP spending (in 2011 US$) for children with ASD in
Israel was $8,288 in 2010 and 2011 (Barret et al., 2012; Raz, Lerner-Geva, Leon,
Chodick, & Gabis, 2013). High OOP spending (<20% of disposable income) can
result in large proportions of family income being consumed by health care costs.
For example, childhood hospitalization in India can cost 178% of mean monthly
household income (Srivastava, Awasthi, & Agarwal, 2009). Likewise, vaginal deliv-
ery costs in Pakistan can exceed 56% of monthly income, and 121% of monthly
income can be spent for cesarean delivery (Khan & Zaman, 2010). OOP health
care spending has also been identified as a leading cause of financial bankruptcy in
the United States (Himmelstein, Thorne, Warren, & Woolhandler, 2009).
The amount of OOP health care spending is inversely related to health care uti-
lization, following the Law of Demand, which is a basic microeconomic concept
that states that consumer demand increases or decreases as price decreases or
increases, respectively (Hildenbrand, 1983). In China, increased OOP spending
was associated with decreased maternal health care utilization, and financial
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difficulties are the primary reason for at-home births (Gao, Barclay, Kildea, Hao, &
Belton, 2010; Yuan, Qian, & Thomsen, 2013). OOP costs have also been associated
with delays in receiving care during delivery in Thailand (Sreeramareddy, Sathya-
narayana, & Kumar, 2012). Moreover, nearly one-third of Indian children with
diarrhea, fever, and cough may not receive treatment due to OOP costs (Liabsue-
trakul & Oumudee, 2011). Conversely, decreases in OOP costs may increase health
care utilization. In addition, following the law of demand, Vietnam’s Health Care
Fund for the Poor has increased health care utilization by reducing OOP costs,
and programs in Bangladesh, China, India, Laos, and the United States have
achieved similar results (Axelson, Bales, Minh, Ekman, & Gerdtham, 2009; Deva-
dasan et al., 2010; Douangvichit, Liabsuetrakul, & McNeil, 2012; Galbraith et al.,
2012; Gopalan & Durairaj, 2012; Kullgren et al., 2010; Long, Zhang, Xu, Tang, &
Hemminki, 2010; Nguyen et al., 2012; Figure 1).
Decreases in health care utilization, in turn, likely decrease health outcomes.
Previously, researchers calculated odds ratios (OR) from aggregated, country-level
data that demonstrated that OOP spending as a percent of total health expenditure
(THE) may be a statistically significant predictor of maternal (OR [95% CI] D 1.32
[1.04, 1.66]), infant (OR [95% CI] D 1.60 [1.28, 2.01]), and child (OR [95%
CI] D 1.64 [1.28, 2.10]) mortality (Muldoon et al., 2011). However, the effect of
the public health care spending in each country on mortality was not investigated.
Here, I sought to determine if the type of health care system utilized moderates the
effect of OOP costs on country-level maternal, infant, and child mortality rates
using publicly available data from the WHO and the World Bank. Such an analysis
has not been performed before. The primary hypothesis is that there is an inverse
relationship between the rate of public funding as a percent of health care spending
and the rate of maternal, infant, and child mortality. A secondary hypothesis is that
there is a direct relationship between OOP costs and mortality rates, regardless of
public funding levels.
Methods
Data
The independent variables of interest were OOP spending as a percent of THE and
public health care expenditure (PHE) as a percent of THE. OOP spending as a per-
cent of THE is defined by the WHO as “expenditure on health by households as
direct payments, discretionary” (World Health Organization, 2012). PHE is
defined as spending from government agencies, donations from international
agencies and nongovernmental organizations, and spending from compulsory
health insurance funds, such as Medicare in the United States (World Bank, 2016).
Three dependent variables were used in the analysis: the maternal mortality
ratio (deaths per 100,000 live births), the infant mortality rate (deaths per
10,000 live births), and the mortality rate for children aged 1–5 years (deaths
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per 10,000 live births). The maternal mortality ratio and the infant mortality
rate were directly measured. The mortality rate for children aged 1–5 years
was not directly available; however, an under-5 mortality (deaths per 10,000
live births) was provided for all included countries. The under-5 mortality
rate includes the infant mortality rate, so the mortality rate for children aged
1–5 years was calculated by subtracting the infant mortality rate from the
under-5 mortality rate in order to remove the influence of the infant mortality
rate on the mortality rate of toddlers and preschool aged children. For exam-
ple, the mortality rate for children aged 1–5 years in Mexico (2.4 deaths per
10,000 live births) was calculated by subtracting the infant mortality rate (14.4
deaths per 10,000 live births) from the under-5 mortality rate (16.8 deaths per
10,000 live births) (i.e. 16.8/10,000 – 14.4/10,000 D 2.4/10,000).
Several covariates were included in the analysis. THE per capita (in 2010 US$)
was used to control for health care spending from all sources, and GDP per capita
(in 2010 US$) was included to control for overall country income. Increases in
GDP per capita have been associated with decreases in maternal and infant mortal-
ity in previous studies (Bradley, Elkins, Herrin, & Elbel, 2011). Country fertility
rates (births per female) were included to control for increased cumulative mortal-
ity risk associated with an increased number of pregnancies, and population
growth (%) was included because previous research has indicated that increased
population growth is associated with an increase in maternal and child mortality
(Sonneveldt, DeCormier Plosky, & Stover, 2013). Health care access was controlled
for using two different covariates contingent on the dependent variable. For mater-
nal mortality, the percent of births attended by skilled health staff, which was
defined as personnel with sufficient expertise to supervise, care for, and provide
advice to women during pregnancy, labor, and the postpartum period, and who
are trained to conduct deliveries and care for newborns independently, was used.
For infant mortality and the mortality rate for children aged 1–5 years, the measles
vaccination rate (%) was used as a proxy (Muldoon et al., 2011). Measles vaccina-
tion has been part of the WHO and United Nations Children’s Fund’s Global
Immunization Vision and Strategy since 2006 (WHO & United Nations Children’s
Fund, 2005).
Data from 2010 were selected for analysis due to data completeness; how-
ever, some data substitutions were required. The percent of births attended by
skilled health staff was not collected from all countries in 2010. The arithmetic
mean between 2006 and 2010 was used instead of the 2010 figure alone.
Years prior to 2006 were thought to no longer accurately represent existing
conditions of health care access. Only countries with information for all
remaining independent and dependent variables were included in the analysis.
OOP as a percent of THE was obtained from the WHO’s Global Health
Expenditure Database (GHED; World Health Organization, 2012). All other
data were obtained from the World Banks’s World Development Indicators
database (World Bank, 2013).
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Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics for Windows, version
21.0 (Armonk, NY, USA). All variables included in the analysis were examined for
symmetry, skewness, and kurtosis prior to analysis. Due to high degrees of skew-
ness (i.e., skewness> 1.0) and kurtosis (i.e., kurtosis> 1.0), both primary indepen-
dent variables and all covariates were condensed into quartiles to eliminate the
possibility that the skewed continuous variables could bias the results. The depen-
dent variables, which were the maternal mortality ratio, the infant mortality rate,
and the mortality rate for children aged 1-5 years, were maintained as continuous.
Generalized linear models specified with a Poisson distribution and a log link func-
tion were used to determine the effect of the OOP spending and PHE on each mea-
sure of mortality. Wald x2 values were used to test significance. The interaction
between the primary independent variables was included in the models by specify-
ing the OOP spending and PHE interaction in the syntax of the SPSS GENLIN
procedure. In cases where this interaction was statistically significant, pairwise
comparisons with the Bonferroni correction, used to limit Type I error, were used
to determine differences between categories. The principal comparisons were those
between countries with high OOP spending and low PHE and countries with low
OOP spending and high PHE. The results were also examined for any consistent
trends within categories (e.g., decreases in mortality as PHE increases within an
OOP spending category). Because SPSS applies the Bonferroni correction by multi-
plying the uncorrected p-value by the number of comparisons, which is
Figure 1. Global distribution of out-of-pocket spending as a percent of total health expenditure
(Source: World Health Organization, 2012).
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mathematically equivalent to dividing alpha by the number of comparisons, an
alpha level of 0.05 was selected a priori for all significance tests.
The University of Connecticut Health Center Institutional Review Board deter-
mined this study was not considered human subjects research.
Results
Data were available for 173 of the 194 (89.2%) countries in the GHED. Excluded
countries had a statistically significant lower GDP per capita (p < 0.01), but no
statistically significant differences were detected for any other variable
(ps > 0.1). Using WHO’s classification system, there were 49 countries from
Europe (28.3%), 42 from Africa (24.3%), 32 from the Americas (18.5%), 21 from
the Western Pacific (12.1%), 19 from the Eastern Mediterranean (11.0%), and 10
from South-East Asia (5.8%). There were 33 low-income countries (15.0%, GDP
per capita < $1,045), 45 lower middle-income countries (27.7%, GDP per
capita D $1,05–$3,975), 48 upper middle-income countries (26.6%, GDP per
capita D $3,976–$12,275), and 47 high-income countries (30.6%, GDP per capita
> $12,275) in the sample.
Median maternal mortality was 65.0 deaths per 100,000 live births, while
median infant and mortality for children aged 1–5 years were 164.0 and 27.0
deaths per 10,000 live births, respectively (Table 1). Median PHE as a percent of
THE was 58.5%, and median OOP spending as a percent of THE was 30.2%.
Figures 1 and 2 show the global distribution of OOP and PHE, respectively. Tables
S1 and S2 list the OOP and PHE by country. In 2010 dollars, median GDP and
health expenditure per capita were $4,442 and $266, respectively. Median popula-
tion growth and fertility rate were 1.3% and 2.4 births per woman, respectively.
Median birth rate attended by skilled health staff was 81.9%, and the median
measles vaccination rate was 93.0%.
Results from the generalized linear models are reported in Table 2. For maternal
(p < 0.001), infant (p < 0.001), and children aged 1–5 mortality (p < 0.001), PHE,
Table 1. Descriptive statistics.
Percentiles
Variable Mean (SD) 25% 50% 75%
Maternal mortality (per 100,000 live births) 172.8 (233.1) 15.5 65.0 230.0
Infant mortality (per 10,000 live births) 279.4 (256.9) 75.5 164.0 436.5
Under 5 mortality (per 10,000 live births) 388.9 (410.2) 87.5 196.0 601.5
Mortality for children aged 1–5 (per 10,000 live births) 109.5 (164.4) 12.5 27.0 152.5
Public health expenditure (% of total health expenditure) 58.1 (18.7) 45.3 58.5 73.9
Out-of-pocket spending (% of total health expenditure) 32.9 (18.7) 17.7 30.2 45.4
GDP per capita (US$) 12,016 (17,573) 1,343 4,442 13,038
Health expenditure per capita (US$) 971 (1,713) 75 266 824
Population growth (% annual) 1.5 (1.5) 0.5 1.3 2.3
Fertility rate (births/woman) 2.9 (1.5) 1.8 2.4 3.8
Births attended by skilled health staff (%) 81.9 (24.1) 62.8 96.6 99.8
Measles vaccination rate (%) 88.1 (12.3) 81.5 93.0 97.0
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Figure 2. Global distribution of public health expenditure as a percent of total health expenditure
(Source: World Bank, 2013).
Table 2. Generalized linear models, effect of public health expenditure and OOP on mortality.
Variable Wald x2 df p
Maternal mortality
PHE 500.990 3 <0.001
OOP spending 2349.973 3 <0.001
GDP per capita 533.913 3 <0.001
Health expenditure per capita 178.963 3 <0.001
Population growth 324.200 3 <0.001
Fertility rate 324.225 3 <0.001
Births attended by skilled health staff 316.974 3 <0.001
OOP spending  PHE 230.889 5 <0.001
Infant mortality
PHE 203.391 3 <0.001
OOP spending 864.862 3 <0.001
GDP per capita 328.071 3 <0.001
Health expenditure per capita 469.344 3 <0.001
Population growth 460.527 3 <0.001
Fertility rate 330.365 3 <0.001
Measles vaccination rate 275.055 3 <0.001
OOP spending  PHE 247.533 5 <0.001
Mortality for children aged 1–5
PHE 97.356 3 <0.001
OOP spending 634.269 3 <0.001
GDP per capita 628.289 3 <0.001
Health expenditure per capita 110.241 3 <0.001
Population growth 334.443 3 <0.001
Fertility rate 616.231 3 <0.001
Measles vaccination rate 532.920 3 <0.001
OOP spending  PHE 165.276 5 <0.001
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OOP spending, and the OOP spending by PHE interaction were statistically signif-
icant. All included covariates were also statistically significant (ps < 0.001).
There were no countries categorized in the extreme categories for both primary
independent variables (i.e., first or fourth quartile for both OOP spending and
PHE). Countries with the highest OOP spending and the lowest PHE had statisti-
cally significant higher rates of maternal (p < 0.001), infant (p < 0.001), and chil-
dren aged 1–5 mortality (p < 0.001) than countries with the lowest OOP spending
and highest PHE (Table 3). For maternal mortality, this difference was approxi-
mately 34 deaths per 100,000 live births. For infant and children aged 1–5 mortal-
ity, this difference was approximately 36.8 and 17 deaths per 10,000 live births,
respectively.
For maternal mortality only, however, the lowest overall rate was within coun-
tries in the second quartile of OOP spending and the highest PHE (Table 4). These
differences were statistically significant (p < 0.001). The highest rate of maternal
mortality occurred in countries with the least OOP spending, which were also in
the third quartile of PHE.
The rates of infant and children aged 1–5 mortality did not follow the maternal
mortality pattern. For the mortality rate for children aged 1–5 years, countries in
the highest PHE quartile for each OOP spending quartile consistently had
Table 3. Estimated marginal means, highest OOP spending/lowest PHE vs. lowest OOP spending/
highest PHE.
Variable Mean 95% CI df p
Maternal mortality
Highest OOP spending/lowest PHE 86.9 64.0, 89.9 1 <0.001
Lowest OOP spending/highest PHE 52.9 50.4, 55.5
Infant mortality
Highest OOP spending/lowest PHE 187.3 183.3, 191.5 1 <0.001
Lowest OOP spending/highest PHE 150.5 146.1, 155.0
Mortality for children aged 1–5
Highest OOP spending/lowest PHE 46.6 44.6, 48.7 1 <0.001
Lowest OOP spending/highest PHE 29.3 27.6, 31.1
Table 4. Estimated marginal means, OOP spending by PHE interaction, maternal mortality only.
OOP spending quartile PHE quartile Mean 95% CI df p
4 2 73.5 68.0, 79.3 1 <0.001
1 86.9 84.0, 89.9 1 <0.001
3 3 72.0 67.4, 76.9 1 <0.001
2 80.4 77.4, 83.5 1 <0.001
1 65.1 60.8, 69.7 1 <0.001
2 4 40.8 36.3, 45.8
3 85.5 82.0, 89.2 1 <0.001
2 67.0 62.3, 72.0 1 <0.001
2 112.0 104.6, 119.9 1 <0.001
1 4 52.9 50.4, 55.5 1 <0.001
3 150.0 138.8, 162.2 1 <0.001
2 100.5 93.9, 107.5 1 <0.001
Reference category.
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statistically significant lower mortality rates than other PHE quartiles (ps D 0.003
to < 0.001; Table 5); however, there was no consistent pattern in mortality rates
from lowest to highest PHE quartile. For instance, in the two lowest OOP spending
quartiles, the mortality rates for children aged 1–5 years in the third PHE quartile
were higher than the mortality rates in the second PHE quartile, with mean differ-
ences of 20 and 35.4 deaths per 10,000 live births, respectively. Decreases in the
mortality rate for children aged 1–5 years as a function of PHE were noted in the 2
highest OOP spending quartiles, however. Conversely, no statistically significant
patterns in infant mortality were noted.
Discussion
My results suggest, similar to previous findings, that, at the country level, OOP
spending is a statistically significant predictor of maternal, infant, and child mor-
tality, and indicate that the effect of OOP spending on mortality may be moder-
ated by country-level PHE. For maternal mortality, the lowest rates observed
occurred when a moderate level of OOP spending (second lowest quartile) was
combined with high PHE (highest quartile). Lower rates of child mortality were
also observed as PHE spending increased, although no discernible patterns
existed for infant mortality.
In general, a statistically significant OOP spending by PHE interaction should
be expected. Research conducted in Africa and Asia demonstrate that the introduc-
tion of publicly funded community and social health insurance schemes improves
health care utilization, quality of care, and social inclusions (Odeyemi & Nixon,
2013; Spaan et al., 2012). In low-income countries, where the gross national
income (GNI) per capita is less than US$1,045, and middle income countries,
where the GNI per capita is between US$1,045 and US$12,746, the pooling of
resources in universal health care programs has increased access to cancer medica-
tions, particularly among the most disadvantaged populations (Lopes Gde, de
Table 5. Estimated marginal means, OOP spending by PHE interaction, mortality for children aged
1–5 only.
OOP spending quartile PHE quartile Mean 95% CI df p
4 2 37.2 33.6, 41.3
1 46.6 44.6, 48.7 1 <0.001
3 3 34.8 31.9, 38.0
2 41.4 39.4, 46.5 1 0.003
1 44.0 40.4, 47.8 1 0.003
2 4 29.0 25.4, 33.2
3 62.7 59.5, 66.2 1 <0.001
2 42.7 38.8, 47.0 1 <0.001
1 94.7 88.0, 101.9 1 <0.001
1 4 29.3 27.6, 31.1
3 108.6 98.8, 119.3 1 <0.001
2 73.2 67.3, 79.7 1 <0.001
Reference category.
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Souza, & Barrios, 2013; World Bank, 2014). Research in Europe has also demon-
strated that publicly funded health care systems are more effective at reducing
health care access inequalities compared to privately funded systems (Gelormino,
Bambra, Spadea, Bellini, & Costa, 2011).
Increases in health care coverage, access, and utilization in publicly financed sys-
tems have translated into improved population health outcomes. Health care cov-
erage without OOP costs provided by the French National Health Insurance
System has eliminated disparities in cardiac catheterizations, coronary interven-
tions, and in-hospital mortality (Danchin et al., 2011). Treatment for cardiovascu-
lar disease is also considered independent of socioeconomic status in the United
Kingdom where equal access to primary treatment options and secondary preven-
tions measures was equal across economic categories (Hawkins et al., 2013). More-
over, findings from Taiwan indicate that geographic health disparities in
appendicitis cases have narrowed after the introduction of a national health insur-
ance scheme (Huang, Yip, Chang, & Chou, 2006), and in the United States, the
requirement to purchase health insurance may empower underprivileged groups
to seek higher level care, even when disparities in low-level health care access
remain (Amri, Stronks, Bordeianou, Sylla, & Berger, 2014).
The importance of publicly financed health care is underscored by contradic-
tions between macrolevel and microlevel OOP spending on health care outcomes.
In Ghana, 2,194 households containing 2,592 children under 5 years old were ran-
domized to either a prepayment scheme group or a fee-for-service practice group
(Ansah et al., 2009). Households in the prepayment scheme had significantly
greater health care utilization rates, but no differences were detected in moderate
anemia, severe anemia, mean hemoglobin concentration, parasite infection, or
mortality, which challenges the assumption that the purchase of health insurance
will result in health gains via increased health care utilization. In Bangladesh, the
Project for Advancing the Health of Newborns and Mothers randomized partici-
pants to one of the three study groups: home care, community care, or the control,
where existing levels of care were neither enhanced nor economically subsidized
(LeFevre et al., 2013). Neonatal deaths were significantly reduced in the home care
arm, but that was accompanied by an approximate 12% increase in OOP health
care spending, implying that greater OOP health care expenditure can lead to
improved health outcomes in the absence of other forms of health care financing.
Although further supporting research is needed, the inconsistencies between
macroeconomic and individual research on the effects of OOP spending indicate
that OOP spending may be a poor policy target for improving health outcomes.
Efforts at improving regional or national health care structures through publicly
financed systems may prove more fruitful, with subsequent decreases in OOP a
positive consequence of such a system. However, decreases in OOP spending with-
out increases in publicly financed health care may have little effect on health since
there would be no subsequent increase in health care availability. The goal may
not be to eliminate OOP health care spending, but to find an appropriate balance
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between OOP spending and PHE. The French health care system may serve as an
example, where the public sector finances approximately 75% of all health care
costs, private insurance covers approximately 15%, and OOP costs cover the
remaining 10% (Mossialos, Wenzl, Osborn, & Anderson, 2015).
Limitations
There are several limitations to this study. First, this is a macroeconomic study
using country-level, aggregated data. Intracountry differences are masked with this
approach, particularly for large, variable countries; causation cannot be deter-
mined; and inferences of individual-level effects should not be made. Second, inter-
country comparisons may be inappropriate as the WHO and the World Bank have
highlighted potential sources of error in data collection, particularly for resource-
poor nations (World Health Organization, 2012). Third, the analysis excludes the
impact of private insurance health expenditures, which is the third component of
health care financing, on mortality. Fourth, mean values for one covariate were
used because of limited data availability, and collapsing continuous variables into
categories could have increased Type II error due to loss of information, although
this effect likely did not occur. Finally, there may be factors associated with mater-
nal, infant, or under-5 mortality such as the availability of fresh food, presence of
clean water, or infectious disease rates that were not included in the analysis.
Conclusions
Maternal, infant, and child mortality remain significant public health problems.
This analysis suggests that country-level OOP spending on health care is associated
with maternal, infant, and child mortality; however, this effect may be moderated
by country-level PHE. Areas with high PHE and moderate levels of OOP spending
appear to have the lowest mortality rates. Programs targeting individual OOP
spending as a means to improve health may be ineffective without simultaneous
increases in health care availability made possible with increased PHE. Further
microlevel and macrolevel research is needed to inform policy makers, health care
providers, and public health professionals about the role of OOP spending and
PHE on health outcomes.
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